Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Clinical Pharmacokinetics|March 7, 2000
Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazolS L Bramer, A SuriClinical Pharmacokinetics|March 7, 2000
Effect of omeprazole on the metabolism of cilostazolA Suri, S L BramerClinical Pharmacokinetics|March 7, 2000
Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarinS Mallikaarjun, S L BramerClinical Pharmacokinetics|March 7, 2000
Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazolS L Bramer, W P ForbesClinical Pharmacokinetics|March 7, 2000
Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokineticsS L Bramer, W P ForbesClinical Pharmacokinetics|January 1, 1997
Effect of food and gastric pH on the bioavailability of grepafloxacinC Efthymiopoulos, S L Bramer, A MaroliClinical Pharmacokinetics|January 1, 1997
Effect of age and gender on the pharmacokinetics of grepafloxacinC Efthymiopoulos, S L Bramer, A MaroliClinical Pharmacokinetics|January 1, 1997
Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young malesC Efthymiopoulos, S L Bramer, A MaroliClinical Pharmacokinetics|March 7, 2000
Effect of renal impairment on the pharmacokinetics of cilostazol and its metabolitesS Mallikaarjun, W P Forbes, S L BramerClinical Pharmacokinetics|March 7, 2000
Effects of CYP3A inhibition on the metabolism of cilostazolA Suri, W P Forbes, S L BramerPageof 3